Objective,2,To observe the clinical effect of modified Qinghua Hezhong(QHHZ) Decoction in the treatment of chronic non-atrophic gastritis (CNAG) with spleen and stomach damp-heat (SSDH) syndrome.,Methods,2,A total of 82 patients with CNAG were randomly divided into treatment group and control group with 41 cases in each group. Patients in the treatment group were treated with modified QHHZ Decoction, while patients in the control group were treated with Rabeprazole Sodium Enteric Coated Capsules. All patients received 4 weeks of treatment. The changes of clinical efficacy, TCM syndrome scores, gastroscopy scores and pathological test scores were observed before and after treatment.,Results,2,①The total effective rate of the treatment group was 92.68%, while that of the control group was 73.17% (,P,<,0.05). The curative effect of the treatment group was better than that of the control group (,P,<,0.05). ②The TCM syndrome scores of spleen and stomach damp-heat syndrome in the two groups were lower than those before treatment respectively, and the differences were statistically significant (,P,<,0.05). After treatment, the TCM syndrome scores of the treatment group was significantly lower than the scores of the control group (,P,<,0.05). ③After treatment, the scores of gastroscopy and pathological test of the treatment group were higher than those of the control group (,P,<,0.05).,Conclusion,2,Qinghua Hezhong Decoction is safe and effective in treating chronic non-atrophic gastritis with spleen and stomach damp-heat syndrome.